Recombinant Human TNFA Protein，His

Tumor Necrosis Factor Alpha (TNFA) is a pivotal cytokine involved in systemic inflammation and is a key regulator of the immune response. Its role extends to various physiological processes, including cell proliferation, differentiation, and apoptosis. TNFA is primarily secreted by macrophages and can influence a wide range of biological activities. Given its critical involvement in inflammation and immune regulation, TNFA has been a focus of research in various fields, including immunology, cancer biology, and autoimmune diseases. Recombinant TNFA proteins have been developed for various therapeutic and research applications. These proteins are used to study TNFA's mechanisms of action, signaling pathways, and its effects on different cell types. Furthermore, the exploration of TNFA's role in diseases like rheumatoid arthritis, Crohn's disease, and cancer has led to the development of targeted therapies, such as TNFA inhibitors. Understanding the structure-function relationship of TNFA and its receptors could provide insights into novel therapeutic strategies and biomarker development. The synthesis and characterization of recombinant TNFA have also advanced with the use of biotechnology, enabling more precise studies in vitro and in vivo. As research progresses, the therapeutic potential of TNFA and its analogs continues to be a promising area, addressing unmet medical needs related to inflammatory disorders and malignancies.